Search For "zydus cadila"
Zydus Cadila seeks nod for its COVID-19 vaccine ZyCoV-D, aims to produce 1
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): The pharmaceutical firm Zydus Cadila on Thursday informed that it has applied for emergency use authorisation (EUA) from the Drug Controller General of India (DCGI) for its DNA vaccine ZyCoV-D against coronavirus disease and stated that they expect to produce
Read More
Zydus Cadila seeks emergency use authorisation for ZyCoV-D COVID-19 vaccin
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): Pharmaceutical major Zydus Cadila on Thursday applied for Emergency Use Authorisation (EUA) seeking approval from the Drugs Controller General of India (DCGI) for the launch of their ZyCoV-D vaccine for 12 years and above, sources said .
Read More
Zydus Cadila COVID-19 vaccine for children above 12 yrs expected by August
Updated : 4 years, 8 months ago IST
New Delhi [India], June 27 (ANI): Zydus Cadila COVID-19 vaccine for children above 12 years is expected to be available by August as its trials are likely to be completed by July-end, said Dr N K Arora, Chairman, National Technical Advisory Group on Immunisation (NTAGI).
Read More
Zydus Cadila likely to seek emergency authorisation for ZyCoV-D COVID-19 v
Updated : 4 years, 8 months ago IST
New Delhi [India], June 18 (ANI): Pharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the next seven-eight days.
Read More
Zydus Cadila, first Indian Company gets recommendation for clinical trials
Updated : 4 years, 9 months ago IST
New Delhi [India], June 4 (ANI): The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of COVID-19 has been recommended to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drug
Read More
Zydus Cadila Q4 net profit up 73 pc at Rs 679 crore
Updated : 4 years, 9 months ago IST
Ahmedabad (Gujarat) [India], May 27 (ANI): Pharmaceutical major Zydus Cadila said on Thursday its net profit jumped 73 per cent year-on-year to Rs 679 crore during the quarter ended March.
Read More
Zydus Cadila seeks DCGI approval for clinical trials for monoclonal antibo
Updated : 4 years, 9 months ago IST
New Delhi [India], May 27 (ANI): Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID-19 infection, the pharmaceutical manufacturer informed on Thursday.
Read More
Cyril Amarchand Mangaldas advises Zydus Cadila on sale of its India-focuse
Updated : 4 years, 10 months ago IST
New Delhi/ Mumbai (Maharashtra) [India], May14 (NewsVoir): Cyril Amarchand Mangaldas advised Zydus Cadila on sale of its India-focussed animal healthcare business to Zenex Animal Health India Private Limited (Zenex), which is a special purpose vehicle set up by Multiples led consortium of in
Read More
Zydus Cadila to sell one animal health business for Rs 2,921 crore
Updated : 4 years, 10 months ago IST
Ahmedabad (Gujarat) [India], May 12 (ANI): Pharmaceutical major Zydus Cadila said on Wednesday it has signed agreements to sell one of its animal health business companies to Multiples Alternate Asset Management led consortium for Rs 2,921 crore.
Read More
DGCI approves emergency use of Zydus's Virafin in treating moderate COVID-
Updated : 4 years, 10 months ago IST
New Delhi [India], April 23 (ANI): Zydus Cadila received emergency use approval from the Drugs Controller General of India (DGCI) on Friday for the use of 'Virafin', Pegylated Interferon alpha-2b (PegIFN) in treating moderate COVID-19 infection in adults.
Read More
Zydus' Virafin gets emergency use approval for treating moderate COVID-19
Updated : 4 years, 10 months ago IST
New Delhi [India], April 23 (ANI): The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults.
Read More
Zydus Cadila seeks DCGI nod for using its hepatitis drug for COVID-19 trea
Updated : 4 years, 11 months ago IST
New Delhi (India) [India], April 5 (ANI): Pharmaceutical Company Zydus Cadila on Monday informed that it has sought approval of the Drugs Controller General of India (DGCI) for using its hepatitis drug for the treatment of coronavirus.
Read More